iBIO PropeliBIO Educate

Board of Directors

Linda FriedmanLinda Friedman

Ms. Friedman received her law degree from Northwestern University School of Law in 1983. Prior to receiving her law degree she graduated Magna Cum Laude, Bronze Tablet (top 3%) from the University of Illinois at Champaign-Urbana in 1980.

After graduation in 1983, Ms. Friedman joined the law firm of Greenbaum & Browne, as an Associate where she was responsible primarily for corporate transactional and general corporate work. In 1988, Ms. Friedman joined the legal department of Lyphomed, Inc. and then left in 1989 to become chief Corporate Counsel at Associated Agencies, where she was similarly responsible for corporate transactional work.

Ms. Friedman joined Fujisawa USA, Inc. (successor to Lyphomed) in 1993 as Corporate Attorney and assumed roles of increasing responsibility. She was promoted to Senior Corporate Counsel, and finally assumed the position of General Counsel in June 1997 and Vice President in June of 1998. In April, 2005 Fujisawa’s parent and Yamanouchi Pharmaceutical Co., Ltd. merged forming Astellas Pharma Inc. At that time, Ms. Friedman was promoted to Senior Vice President of Astellas US. As the US legal head, Ms. Friedman oversees all of the day to day legal responsibilities for the US headquarters and its affiliates. She is also responsible for establishing and overseeing the Corporate Records function at the company and has dotted line responsibility over the US IP group. Ms. Friedman is a member of the Astellas US Senior Executive Committee and works closely with her colleagues around the world especially in Japan and in Europe.

Back


65 East Wacker Place Suite 1600, Chicago, IL 60601 P: 312.422.1111 F: 312.422.1145
The iBIO Institute is a not-for-profit corporation and is tax-exempt as a public charity under Sections 501(c)(3) and 509 of the Internal Revenue Code.